---
title: "BIGHAM MICHAEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/992e9140-7249-5071-aac2-e33535d7d619
json: https://whiteintel.dev/api/public/dossier/992e9140-7249-5071-aac2-e33535d7d619
identifier: sec:0001216917
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# BIGHAM MICHAEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001216917`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/992e9140-7249-5071-aac2-e33535d7d619  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/992e9140-7249-5071-aac2-e33535d7d619  

## Ownership & control

### Holdings / subsidiaries

- **NOVACEA INC** (officer) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb
- **NOVACEA INC** (director) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb
- **FRAZIER LIFESCIENCES ACQUISITION CORP** (director) — https://whiteintel.dev/entity/9bc17048-c8b1-54d6-ac0a-525a34f190f0
- **ADAMAS PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/a442c7d7-09d5-57a9-ad1d-a71e92788696
- **SUPERNUS PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/d5890387-3efb-5936-83a2-aeaec9e38284
- **XENOGEN CORP** (director) — https://whiteintel.dev/entity/5df46796-5452-5fc9-9586-bf6688b97eea
- **XENOGEN CORP** (tenpercentowner) — https://whiteintel.dev/entity/5df46796-5452-5fc9-9586-bf6688b97eea

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BIGHAM MICHAEL**. Human view: https://whiteintel.dev/entity/992e9140-7249-5071-aac2-e33535d7d619 · Structured JSON: https://whiteintel.dev/api/public/dossier/992e9140-7249-5071-aac2-e33535d7d619._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._